These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 38449391)
1. The deubiquitinase BRCC3 increases the stability of ZEB1 and promotes the proliferation and metastasis of triple-negative breast cancer cells. Huang Q; Zheng S; Gu H; Yang Z; Lu Y; Yu X; Guo G Acta Biochim Biophys Sin (Shanghai); 2024 Apr; 56(4):564-575. PubMed ID: 38449391 [TBL] [Abstract][Full Text] [Related]
2. Study on inhibition of Britannin on triple-negative breast carcinoma through degrading ZEB1 proteins. Lu H; Wu Z; Wang Y; Zhao D; Zhang B; Hong M Phytomedicine; 2022 Sep; 104():154291. PubMed ID: 35839735 [TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway. Wang D; Keyoumu K; Yu R; Wen D; Jiang H; Liu X; Di X; Zhang S Mol Med; 2024 May; 30(1):61. PubMed ID: 38760717 [TBL] [Abstract][Full Text] [Related]
4. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC. Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155 [No Abstract] [Full Text] [Related]
5. Hsa-miR-497-3p impedes the proliferation and invasion of triple-negative breast cancer cells by controlling epithelial-mesenchymal transition through ZEB1 targeting. Dong Q; Chen H; Li Y; Kong Y; Geng C; Liu Y Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):78-83. PubMed ID: 37715420 [TBL] [Abstract][Full Text] [Related]
6. Schlafen12 Reduces the Aggressiveness of Triple Negative Breast Cancer through Post-Transcriptional Regulation of ZEB1 That Drives Stem Cell Differentiation. Al-Marsoummi S; Vomhof-DeKrey E; Basson MD Cell Physiol Biochem; 2019; 53(6):999-1014. PubMed ID: 31838790 [TBL] [Abstract][Full Text] [Related]
7. MiR-508-3p inhibits cell invasion and epithelial-mesenchymal transition by targeting ZEB1 in triple-negative breast cancer. Guo SJ; Zeng HX; Huang P; Wang S; Xie CH; Li SJ Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6379-6385. PubMed ID: 30338806 [TBL] [Abstract][Full Text] [Related]
8. ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA. Luo N; Zhang K; Li X; Hu Y J Cell Biochem; 2020 Oct; 121(10):4176-4187. PubMed ID: 31922280 [TBL] [Abstract][Full Text] [Related]
9. STAT3 Targets Ma JH; Qi J; Lin SQ; Zhang CY; Liu FY; Xie WD; Li X Mol Cancer Res; 2019 Nov; 17(11):2184-2195. PubMed ID: 31427441 [TBL] [Abstract][Full Text] [Related]
10. ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1. Song W; Tang L; Xu Y; Sun Q; Yang F; Guan X J Exp Clin Cancer Res; 2017 Jun; 36(1):75. PubMed ID: 28583190 [TBL] [Abstract][Full Text] [Related]
11. Radiation exposure triggers the progression of triple negative breast cancer via stabilizing ZEB1. Lin Y; Bai X; Zhou W; He Y; Wu Y; Wang X Biomed Pharmacother; 2018 Nov; 107():1624-1630. PubMed ID: 30257380 [TBL] [Abstract][Full Text] [Related]
12. Pomegranate peel extract inhibits expression of β-catenin, epithelial mesenchymal transition, and metastasis in triple negative breast cancer cells. Bagheri M; Fazli M; Saeednia S; Kor A; Ahmadiankia N Cell Mol Biol (Noisy-le-grand); 2018 May; 64(7):86-91. PubMed ID: 29974851 [TBL] [Abstract][Full Text] [Related]
13. Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators. Rhodes LV; Tate CR; Segar HC; Burks HE; Phamduy TB; Hoang V; Elliott S; Gilliam D; Pounder FN; Anbalagan M; Chrisey DB; Rowan BG; Burow ME; Collins-Burow BM Breast Cancer Res Treat; 2014 Jun; 145(3):593-604. PubMed ID: 24810497 [TBL] [Abstract][Full Text] [Related]
14. Knockdown of ZEB1 suppressed the formation of vasculogenic mimicry and epithelial-mesenchymal transition in the human breast cancer cell line MDA-MB-231. Liang W; Song S; Xu Y; Li H; Liu H Mol Med Rep; 2018 May; 17(5):6711-6716. PubMed ID: 29512767 [TBL] [Abstract][Full Text] [Related]
15. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition. Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486 [TBL] [Abstract][Full Text] [Related]
16. [Effect and mechanism of Compound Shougong Powder in attenuating triple-negative breast cancer progression by reversing epithelial-to-mesenchymal transition]. Jiao ZY; Zhu YF; Chen ST; Pan YX; Song H; Chen FY Zhongguo Zhong Yao Za Zhi; 2024 Jul; 49(14):3868-3877. PubMed ID: 39099360 [TBL] [Abstract][Full Text] [Related]
17. Deubiquitinase BRCC3 promotes the migration, invasion and EMT progression of colon adenocarcinoma by stabilizing MET expression. Feng X; He S; Chen Y; Zhang L Genes Genomics; 2024 May; 46(5):637-646. PubMed ID: 38470543 [TBL] [Abstract][Full Text] [Related]
18. The transcription factor ZEB1 mediates the progression of epithelial ovarian cancer by promoting the transcription of CircANKRD17. Cai W; Zhang Q J Biochem Mol Toxicol; 2022 Aug; 36(8):e23086. PubMed ID: 35521974 [TBL] [Abstract][Full Text] [Related]
19. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer. Ji H; Sang M; Liu F; Ai N; Geng C Pathol Res Pract; 2019 Apr; 215(4):697-704. PubMed ID: 30611621 [TBL] [Abstract][Full Text] [Related]
20. Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells. Hugo HJ; Pereira L; Suryadinata R; Drabsch Y; Gonda TJ; Gunasinghe NP; Pinto C; Soo ET; van Denderen BJ; Hill P; Ramsay RG; Sarcevic B; Newgreen DF; Thompson EW Breast Cancer Res; 2013 Nov; 15(6):R113. PubMed ID: 24283570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]